Solid Biosciences Inc (NAS:SLDB)
$ 8.51 -0.61 (-6.69%) Market Cap: 326.61 Mil Enterprise Value: 169.77 Mil PE Ratio: 0 PB Ratio: 1.64 GF Score: 40/100

Solid Biosciences Inc at BMO Capital Markets BioPharma Spotlight Series: Genetic Medicine Delivery (Virtual) Transcript

Mar 28, 2023 / 01:00PM GMT
Release Date Price: $3.97 (+2.32%)
Bert Powell
BMO Capital Markets Equity Research - Global Director of Equity Research

Good morning. My name is Bert Powell, and I'm the Global Director of Research here at BMO Capital Markets. So it's my pleasure to welcome you to today's Biopharma Spotlight Series on novel technologies for the delivery of genetic medicines.

It's an important new class of medicines that are the emerging technology in life sciences today. BMO Capital Markets biotech research analyst Kostas Biliouris will moderate all 4 of today's panel discussions. Each panel will take a deep dive with the companies who are leading the research and the development genetic medicines through adeno-associated viruses, where in a naturally occurring virus is converted into a delivery mechanism for genetic medicines, lipid nanoparticles were nanoparticles comprised of lipids and were used in COVID vaccines and other delivery platforms that can potentially address some of the limitations in adeno-associated viruses and lipid nanoparticles.

Our last panel today will focus on the drug delivery in the CNS space, and we look

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot